March 27, 2017 10:18 AM ET

Biotechnology

Company Overview of Quanterix Corporation

Key Executives for Quanterix Corporation

NameBoard RelationshipsTitleAge
Kevin Hrusovsky 16 RelationshipsExecutive Chairman and Chief Executive Officer--
David R. Walt Ph.D.50 RelationshipsCo-Founder, Chairman of Scientific Advisory Board and Director63
Ernest Orticerio No RelationshipsChief Financial Officer and Vice President of Finance & Administration--
David Duffy Ph.D.No RelationshipsChief Technology Officer and Vice President of Research--

Quanterix Corporation Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kevin Hrusovsky 16 RelationshipsQuanterix Corporation--
David R. Walt Ph.D. 50 RelationshipsQuanterix Corporation63
Keith L. Crandell MBA 71 RelationshipsArch Venture Partners, L.P.56
Robert M. Corn Ph.D. 18 RelationshipsGWC Technologies, Inc.--
Larry J. Kricka D. Phil., F.A.C.B., F.R.S.C. C.Chem., F.R.C.Path 67 RelationshipsCapitalBio Corporation--
View All Board Members

Quanterix Corporation Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.David R. Walt50 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
321.1K
Bonus
243.8K
Total Short Term Compensation
404.2K
Total Value of Options
2.9M
Compensation as of Fiscal Year
Quanterix Corporation CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Mobidiag Ltd Opens New Office in United Kingdom; Appoints Stuart Cranmer as Managing Director
March 27, 2017 7:00 AM ET
Orgenesis Inc. Announces Resignation of Etti Hanochi from its Board of Directors
March 24, 2017 4:38 PM ET
Silicon Therapeutics Appoints Woody Sherman as Chief Scientific Officer
March 24, 2017 2:15 PM ET
Retrophin, Inc. Appoints John A. Orwin to Board of Directors
March 23, 2017 9:11 PM ET
Arbutus Biopharma Corporation Appoints Daniel Burgess to the Board of Directors and Audit Committee
March 23, 2017 8:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Quanterix Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.